Join Vor in tackling autoimmune disease at its root by advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor. Contribute to a medicine with best-in-disease Phase 3 results in myasthenia gravis and expansion into multiple autoimmune diseases.
Requirements
- Advanced degree in a life science field (PhD, PharmD, MD/DO) preferred
- 3+ years of MSL or equivalent field-based medical affairs experience in the biotech or pharmaceutical industry
- Prior MSL experience in myasthenia gravis strongly preferred
- Knowledge of medical and regulatory standards guiding interactions with healthcare professionals
Benefits
- Comprehensive health coverage
- Flexible paid time off
- Generous parental leave
- Competitive 401(k)
- Education assistance
- Wellness resources
- Financial security